CECC announces ACIP's recommendations on rollout of Moderna's second-generation bivalent COVID-19 vaccine, booster dose interval, and use of Novavax COVID-19 vaccine in adolescents aged 12-17

The ACIP recommendations are listed below.

1. In response to the potential risks associated with the gradual easing of border measures, the bivalent vaccine to be imported at the end of September is recommended to be used as a booster dose and rolled out in two phases.
2. II. In response to the possible further spread of the variants and recent increases in the number of cases, the ACIP recommends changing the minimum interval between the last COVID-19 dose and a booster shot (including the current monovalent vaccines and the second-generation bivalent vaccine) to at least three months.

Please click here to see further details.